A detailed history of Cetera Investment Advisers transactions in Zomedica Corp. stock. As of the latest transaction made, Cetera Investment Advisers holds 258,001 shares of ZOM stock, worth $30,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares
258,001
Previous 258,153 0.06%
Holding current value
$30,960
Previous $38,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 22, 2024

SELL
$0.12 - $0.18 $18 - $27
-152 Reduced 0.06%
258,001 $38,000
Q1 2024

May 24, 2024

BUY
$0.12 - $0.19 $30,978 - $49,049
258,153 New
258,153 $38,000
Q2 2023

Aug 09, 2023

SELL
$0.19 - $0.22 $95 - $110
-500 Reduced 2.69%
18,100 $3,000
Q4 2022

Feb 14, 2023

BUY
$0.16 - $0.25 $2,976 - $4,650
18,600 New
18,600 $2,000
Q1 2021

May 17, 2021

SELL
$0.35 - $2.7 $7,314 - $56,430
-20,900 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$0.07 - $0.25 $1,463 - $5,225
20,900 New
20,900 $5,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $118M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.